Clinical Trial Proves Promising for Pancreatic Cancer Patients

feeds has 409 videos Subscribe Here

Description: Wen Wee Ma, MBBS, Assistant Professor, GI Oncology at Roswell Park Cancer Institute, explains the results of the MPACT study, in which RPCI participated. The study showed that survival of late-stage pancreatic cancer patients who received a combination of Abraxane and and gemcitabine, was almost two months longer than patients who received only gemcitabine.
Shared By : feeds
Posted on : 04/22/13
Added : 5 years ago
Category : Pancreatic Cancer

More From feeds

Nothing found.